Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

AB SCIEX and LECO Announces Co-marketing Agreement

Published: Wednesday, March 20, 2013
Last Updated: Wednesday, March 20, 2013
Bookmark and Share
Bundled solutions leverage the synergy between two technology leaders.

LECO Corporation and AB SCIEX have announced a co-marketing agreement to cooperatively offer bundled liquid chromatography (LC) and gas chromatography (GC) mass spectrometry-based solutions to metabolomics researchers who require both types of separation capabilities.

Metabolomics researchers often require the use of both GC/MS and LC/MS technologies to provide comprehensive coverage of the analytes in their biological systems as part of the Systems Biology approach.

The new AB SCIEX/LECO bundled solutions will provide these researchers with high speed, accurate mass capabilities with LC and GC, along with robust nominal mass GC/MS and triple quadrupole mass spectrometry.

Researchers will have at their disposal pairings of time-tested nominal mass systems as well as industry-leading high performance GC-TOF and LC-QTOF MS systems.

The application support and service teams of both companies will work together to ensure that users get the support they need to run their comprehensive experiments.

“As the industry leader in LC/MS, we interact with metabolomics researchers all over the world, and we understand that there are times when metabolomics researchers want to use both GC/MS and LC/MS,” said Aaron Hudson, Senior Director, Academic and Omics Business.

Hudson continued, “Representing a virtual one-stop shop for metabolomics mass spectrometry, the joint bundles from AB SCIEX and LECO provide users with greater flexibility in chromatography while obtaining the rich information that MS/MS delivers.”

“Bringing together leaders in GC/MS and LC/MS and facilitating the availability of our systems as complementary technologies helps ensure that metabolomics researchers can approach their work to obtain the very best data and information available,” said Jeffrey Patrick, Director of Marketed Technologies for LECO.

Patrick continued, “Our leadership in GC/MS technologies is a perfect complement to the offerings of AB SCIEX and puts the combined power of our product portfolios, expertise, services, and support to work for these researchers.”

The joint bundles from AB SCIEX and LECO will be available in North America and Europe.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

LECO Announces Special Events at ASMS
Company to host a series of events during the conference held at the America’s Center, Saint Louis, MO on May 31-June 4.
Tuesday, May 12, 2015
Metabolomics Symposium Scheduled for November 4 in Dallas
Event is sponsored by LECO, AB SCIEX, GERSTEL and UT Southwestern Medical Center.
Tuesday, October 22, 2013
LECO Supports New West Coast Metabolomics Center
The West Coast Metabolomics Center will receive access to the LECO Citius™ LC-HRT.
Monday, September 16, 2013
LECO Announces Special Events at ASMS
Special events at the 61st ASMS Conference on Mass Spectrometry and Allied Topics, June 9-13 in Minneapolis.
Thursday, June 06, 2013
LECO and Genedata Collaborate on Mass Spectrometry Data Analysis
Efficient mass spectrometry data analysis capabilities now available to a broad range of pharmaceutical, industrial biotech, and life science companies.
Thursday, September 27, 2012
LECO Partners with the Joint Mass Spectrometry Centre
The LECO European Life Sciences and Chemical Analysis Centre is providing access to high resolution mass spectrometry instrumentation to the Joint Mass Spectrometry Centre.
Wednesday, August 22, 2012
LECO Corporation Opens New Separation Science R&D Facility
Newest addition of Michigan-the Elizabeth S. Warren Technical Centre.
Tuesday, June 05, 2012
LECO Opens Global Support Center
The new building will house its Service, Customer Training, and Consumables departments, as well as three mobile laboratories.
Wednesday, January 11, 2006
Scientific News
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
NIH Study Finds Link Between Depression, Gestational Diabetes
Researchers at NIH have discovered that the depression in early pregnancy doubles risk for gestational diabetes, and gestational diabetes increases risk for postpartum depression.
Gut Pathogens Thrive on Body's Tissue-Repair Mechanism
Researcher have discovered that harm caused by pathogens in the intestinal tract benefit from immune system response to damaged intestinal lining.
Cancer's Taste for Fat
Researchers discovered signalling pathway for fat burning is disrupted in certain cancers.
‘Tracking Bugs’ Reveal Secret of Cancer Cell Metabolism
Unexpected finding shows instead of throwing away valuable nutrients, the cells squeeze out every last drop of energy.
Ginger Nano-Lipid Particles May Improve Cancer Treatment
Edible ginger-derived nano-lipids show promise for effectively targeting and delivering chemotherapeutic drugs used to treat colon cancer.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
Absolute Quantification of Mitochondrial Metabolites
Scientists have developed a method to quickly isolate and systematically measure metabolite concentrations within mitochondria.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
Demonstrating LNP Delivery of CRISPR Components
Intellia has presented data demonstrating in vivo gene editing ising liquid nanoparticles (LNPs) to deliver CRISPR/Cas9.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!